119 related articles for article (PubMed ID: 11501769)
1. Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced fallopian tube carcinoma. An EORTC gynecological cancer group study. European Organization for Research and Treatment of Cancer.
Wagenaar HC; Pecorelli S; Vergote I; Curran D; Wagener DJ; Kobierska A; Bolis G; Bokkel-Huinink WT; Lacave AJ; Madronal C; Forn M; de Oliveira CF; Mangioni C; Nooij MA; Goupil A; Kerbrat P; Marth CH; Tumolo S; Herben MG; Zanaboni F; Vermorken JB
Eur J Gynaecol Oncol; 2001; 22(3):187-93. PubMed ID: 11501769
[TBL] [Abstract][Full Text] [Related]
2. Treatment of fallopian tube carcinoma with cisplatin, doxorubicin, and cyclophosphamide.
Morris M; Gershenson DM; Burke TW; Kavanagh JJ; Silva EG; Wharton JT
Obstet Gynecol; 1990 Dec; 76(6):1020-4. PubMed ID: 2234710
[TBL] [Abstract][Full Text] [Related]
3. Treatment of fallopian tube carcinoma with cyclophosphamide, adriamycin, and cisplatin.
Cormio G; Maneo A; Gabriele A; Zanetta G; Losa G; Lissoni A
Am J Clin Oncol; 1997 Apr; 20(2):143-5. PubMed ID: 9124187
[TBL] [Abstract][Full Text] [Related]
4. Treatment of primary fallopian tube carcinoma with cisplatin-containing chemotherapy.
Pectasides D; Barbounis V; Sintila A; Varthalitis I; Dimitriadis M; Athanassiou A
Am J Clin Oncol; 1994 Feb; 17(1):68-71. PubMed ID: 8311012
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma.
Shin DM; Fossella FV; Umsawasdi T; Murphy WK; Chasen MH; Walsh G; Komaki R; McMurtrey MJ; Hong WK
Cancer; 1995 Dec; 76(11):2230-6. PubMed ID: 8635025
[TBL] [Abstract][Full Text] [Related]
6. Long-term results in patients with advanced epithelial ovarian carcinoma treated with a combination of cisplatin, doxorubicin, and cyclophosphamide.
Colozza M; Mosconi AM; Gori S; Belsanti V; Basurto C; De Angelis V; Giansanti M; Tonato M
Am J Clin Oncol; 1997 Oct; 20(5):522-6. PubMed ID: 9345342
[TBL] [Abstract][Full Text] [Related]
7. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
Gadducci A; Landoni F; Sartori E; Maggino T; Zola P; Gabriele A; Rossi R; Cosio S; Fanucchi A; Tisi G
Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942
[TBL] [Abstract][Full Text] [Related]
8. Primary carcinoma of the fallopian tube: evidence for activity of cisplatin combination therapy.
Maxson WZ; Stehman FB; Ulbright TM; Sutton GP; Ehrlich CE
Gynecol Oncol; 1987 Mar; 26(3):305-13. PubMed ID: 3557196
[TBL] [Abstract][Full Text] [Related]
9. ICON 2 and ICON 3 data in previously untreated ovarian cancer: results to date.
Harper P
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-23-S15-25. PubMed ID: 9346217
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of primary fallopian tube adenocarcinoma: report of 25 patients.
Wang PH; Yuan CC; Chao HT; Juang CM; Ng HT
Eur J Gynaecol Oncol; 1998; 19(6):571-4. PubMed ID: 10215444
[TBL] [Abstract][Full Text] [Related]
11. Combination of cisplatin-doxorubicin-cyclophosphamide in adenocarcinoma of unknown primary site: a phase II trial.
Guardiola E; Pivot X; Tchicknavorian X; Magne N; Otto J; Thyss A; Schneider M
Am J Clin Oncol; 2001 Aug; 24(4):372-5. PubMed ID: 11474265
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group.
van Wijk FH; Aapro MS; Bolis G; Chevallier B; van der Burg ME; Poveda A; de Oliveira CF; Tumolo S; Scotto di Palumbo V; Piccart M; Franchi M; Zanaboni F; Lacave AJ; Fontanelli R; Favalli G; Zola P; Guastalla JP; Rosso R; Marth C; Nooij M; Presti M; Scarabelli C; Splinter TA; Ploch E; Beex LV; ten Bokkel Huinink W; Forni M; Melpignano M; Blake P; Kerbrat P; Mendiola C; Cervantes A; Goupil A; Harper PG; Madronal C; Namer M; Scarfone G; Stoot JE; Teodorovic I; Coens C; Vergote I; Vermorken JB;
Ann Oncol; 2003 Mar; 14(3):441-8. PubMed ID: 12598351
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of doxorubicin/docetaxel/cyclophosphamide for locally advanced and metastatic breast cancer: results from NSABP trial BP-58.
Smith RE; Anderson SJ; Brown A; Scholnik AP; Desai AM; Kardinal CG; Lembersky BC; Mamounas EP
Clin Breast Cancer; 2002 Dec; 3(5):333-40. PubMed ID: 12533263
[TBL] [Abstract][Full Text] [Related]
14. Results of chemotherapy in advanced carcinoma of the fallopian tube.
Peters WA; Andersen WA; Hopkins MP
Cancer; 1989 Mar; 63(5):836-8. PubMed ID: 2914291
[TBL] [Abstract][Full Text] [Related]
15. Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer.
Barlin JN; Dao F; Bou Zgheib N; Ferguson SE; Sabbatini PJ; Hensley ML; Bell-McGuinn KM; Konner J; Tew WP; Aghajanian C; Chi DS
Gynecol Oncol; 2012 Jun; 125(3):621-4. PubMed ID: 22446622
[TBL] [Abstract][Full Text] [Related]
16. High-dose cisplatin, etoposide, and cyclophosphamide with autologous stem cell reinfusion in patients with responsive metastatic or high-risk primary breast cancer.
Somlo G; Doroshow JH; Forman SJ; Leong LA; Margolin KA; Morgan RJ; Raschko JW; Akman SA; Ahn C; Sniecinski I
Cancer; 1994 Jan; 73(1):125-34. PubMed ID: 7903906
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel/carboplatin versus cyclophosphamide/adriamycin/cisplatin as postoperative adjuvant chemotherapy for advanced endometrial adenocarcinoma.
Hidaka T; Nakamura T; Shima T; Yuki H; Saito S
J Obstet Gynaecol Res; 2006 Jun; 32(3):330-7. PubMed ID: 16764625
[TBL] [Abstract][Full Text] [Related]
18. Prospective sequential trials of induction weekly cisplatin followed by monthly cisplatin, doxorubicin, cyclophosphamide and paclitaxel and cisplatin in optimal (< or = 1 cm) stage III and IV ovarian cancer.
Piver MS; Eltabbakh GH; Hempling RE; Recio FO; Blumenson LE
Eur J Gynaecol Oncol; 1998; 19(1):5-10. PubMed ID: 9476049
[TBL] [Abstract][Full Text] [Related]
19. Adenocarcinoma of the fallopian tube: report of a case with an unusual pattern of metastasis and response to combination chemotherapy.
Young JA; Kossman CR; Green MR
Gynecol Oncol; 1984 Feb; 17(2):238-40. PubMed ID: 6546733
[TBL] [Abstract][Full Text] [Related]
20. [Combination chemotherapy using cyclophosphamide, adriamycin, and cisplatin in recurrent or advanced endometrial cancer--a preliminary report].
Baba S; Kashimura M; Shinohara M; Kusano S; Sasayama T; Hamasaki K
Gan No Rinsho; 1989 Feb; 35(3):371-7. PubMed ID: 2926985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
